Global @dvisor welcomes Serbia
The global national economic assessment holds steady this month, as four in ten (40%) respondents around the world rate their national economy "as good". North America is a regional winner in February, as both the United States (55%, +3 pts.) and Canada (55%, +3 pts.) show improvement since last sounding. Both Middle East (43%, -2 pts.) and Latin America (27%, -1 pt.) lose ground this month. The assessment average for all other regions remains unchanged.
The local economic assessment average (30%) is down for a second month in a row. Regional players that drive the average lower this sounding are Middle East/Africa (37%, -2 pts.) and Latin America (19%, -1 pt.).
The future national economic assessment remains unchanged since last sounding, as one quarter (26%) of respondents expect their national economy to be "stronger" in the next 6 months. Most of the regions stay in the positive territory, with only Europe (13%, -2 pts.) and Latin America (43%, -1 pt.) being down since January.
Global Average of National Economic Assessment Unchanged: 40%
The average global economic assessment of national economies surveyed in 25 countries remains unchanged with 40% of global citizens rating their national economies as ‘good’.
Global Average of Local Economic Assessment (30%) Down One Points
When asked to assess their local economy, nearly one third (30%) of those surveyed in 25 countries agree that the state of the current economy in their local area is ‘good’. The local economic assessment is down one point since last sounding.
Global Average of Future Outlook for Local Economy (26%) Unchanged
The future outlook is unchanged since last month, with one quarter (26%) of global citizens surveyed in 25 countries expecting their local economy to be stronger six months from now.
[WEBINAR] Messaging & Motivation: Engaging Participants in Healthcare Research
August 27 - One of the biggest challenges researchers face is recruiting and retaining participants, especially for longitudinal studies or intense clinical trials. Join us for a complimentary webinar to learn innovative ways to enhance recruitment, and maintain participant engagement.
[EVENT] International Conference on Pharmacoepidemiology & Therapeutic Risk Management
August 22-26, Ipsos Healthcare’s Global Evidence, Value and Access (GEVA) team will be exhibiting at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) being held in Prague, CZ.